SYK.NYSEStryker CORP

Form 4: Stryker VP Granted Stock Options Under Incentive Plan

Sentiment:

Insider Transaction Report


Stryker's VP, Chief Digital and Information Officer, Debra King, was granted 3,992 employee stock options under the company's long-term incentive plan.

Summary

  • Debra King, VP, Chief Digital and Information Officer of Stryker Corp (SYK), was granted 3,992 employee stock options.
  • The options were granted on February 4, 2026, with an exercise price of $360.82 per share.
  • These options become exercisable as to 20% on each of the first five anniversaries of the grant date.
  • The options expire on February 3, 2036.
  • The grant was made pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan.
  • The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, reflecting standard executive compensation practices and alignment of interests, without indicating any significant operational or financial changes for the company.

Positives

  • Granting of stock options aligns management's interests with shareholder value creation.
  • The transaction was pre-planned under a Rule 10b5-1(c) plan, indicating a structured approach to equity compensation.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance, only details of an insider's equity compensation.

Management Comments

  • "VP, Chief Digital and Information Officer."
  • "Stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant."

Industry Context

StockSavvy.ai notes that equity compensation, particularly through stock options, is a standard practice across the medical technology and healthcare industry to incentivize executives and align their long-term interests with shareholder value. This grant to a key digital and information officer highlights the increasing importance of technology leadership within the sector.

Comparison to Industry Standards

  • The grant of stock options as part of executive compensation is a common practice, comparable to compensation structures at peers like Medtronic (MDT) or Johnson & Johnson (JNJ), which also utilize long-term incentive plans to retain and motivate key personnel.
  • The vesting schedule of 20% over five years is a typical structure designed to encourage long-term commitment and performance.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Power of Attorney GrantDebra King granted power of attorney to several individuals to facilitate her SEC filings, including Forms 3, 4, and 5, and to manage her EDGAR account.2025-09-01This is an administrative change to streamline compliance with SEC reporting requirements for insider transactions, ensuring timely and accurate filings.

Stakeholder Impact

  • Shareholders: The grant aligns executive incentives with long-term shareholder value.
  • Employees: Reflects standard executive compensation practices within the company.

Next Steps

  • The options will become exercisable as to 20% on each of the first five anniversaries of the grant date (starting February 4, 2027).

Key Dates

DateDescription
2025-09-01Effective date of Power of Attorney granted by Debra King.
2026-02-04Date of employee stock option grant to Debra King.
2026-02-06Date Form 4 was signed by attorney-in-fact for Debra King.
2036-02-03Expiration date of the granted employee stock options.

Recommendation

hold

This Form 4 filing details a routine equity compensation grant to an executive, which is a standard practice and does not provide new information that would alter the fundamental investment thesis for Stryker. The transaction was pre-planned under a 10b5-1 plan, further reducing any speculative implications. Therefore, a 'hold' recommendation is appropriate as this event alone does not warrant a change in investment stance.

Keywords

Stryker, SYK, Stock Option Grant, Insider Transaction, Form 4, Debra King, Equity Compensation, Long-Term Incentive Plan, Rule 10b5-1

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.